Over the past five years, the lung cancer survival rate has increased by 14 percent. A large part of that change is driven by advances in immunotherapy—typically implemented alongside treatments like chemotherapy to give patients the best chance at positive outcomes.
If xenotransplantation is the future, then the future is closer than we think. It's now priority to many transplantation surgeons and experts because it could address many of the barriers that have existed in organ access for decades.
Hundreds of patients have received lung transplants due to COVID-19 in the US. Dr. Selim Arcasoy discusses Covid-19 lung damage, and what this means for patients, surgeons, and the future of transplant surgery.
Dr. Melina Wald, Dr. Christine Rohde, and Dr. Jeffery Ascherman discuss gender identity care—everything from seeking treatment, potential insurance issues, medical therapy, surgical interventions, and collaboration.
Treating generations of families with rare hereditary colorectal cancers requires much of a different approach, one that includes caring for children. Dr. James Church discusses leading with compassion, empathy, and understanding before all else and tailoring treatments to individuals and their families.